Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1982 1
1983 3
1986 2
1987 1
1989 1
1991 1
1992 3
1993 1
1995 3
1997 1
1998 1
1999 3
2000 2
2001 1
2002 2
2003 2
2004 4
2005 1
2006 1
2007 1
2008 4
2009 2
2010 2
2011 4
2012 5
2013 3
2014 8
2015 7
2016 6
2017 5
2018 5
2019 8
2020 14
2021 12
2022 6
2023 9
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

124 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Primary release disorder of platelets"
Page 1
Cancer-associated venous thromboembolism: Burden, mechanisms, and management.
Ay C, Pabinger I, Cohen AT. Ay C, et al. Thromb Haemost. 2017 Jan 26;117(2):219-230. doi: 10.1160/TH16-08-0615. Epub 2016 Nov 24. Thromb Haemost. 2017. PMID: 27882374 Review.
In this review, we discuss the epidemiology and burden of the disease, the pathophysiology of cancer-associated VTE, and the clinical treatment options for both primary prevention and acute treatment. ...Furthermore, blood count parameters (e.g. platelets …
In this review, we discuss the epidemiology and burden of the disease, the pathophysiology of cancer-associated VTE, and the clinical …
Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study.
Schuster SJ, Tam CS, Borchmann P, Worel N, McGuirk JP, Holte H, Waller EK, Jaglowski S, Bishop MR, Damon LE, Foley SR, Westin JR, Fleury I, Ho PJ, Mielke S, Teshima T, Janakiram M, Hsu JM, Izutsu K, Kersten MJ, Ghosh M, Wagner-Johnston N, Kato K, Corradini P, Martinez-Prieto M, Han X, Tiwari R, Salles G, Maziarz RT. Schuster SJ, et al. Lancet Oncol. 2021 Oct;22(10):1403-1415. doi: 10.1016/S1470-2045(21)00375-2. Epub 2021 Sep 10. Lancet Oncol. 2021. PMID: 34516954 Clinical Trial.
Patients received a single intravenous infusion of tisagenlecleucel (target dose 5 10(8) viable transduced CAR T cells). The primary endpoint was overall response rate (ie, the proportion of patients with a best overall disease response of a complete response or par …
Patients received a single intravenous infusion of tisagenlecleucel (target dose 5 10(8) viable transduced CAR T cells). The primary …
Splinting for carpal tunnel syndrome.
Karjalainen TV, Lusa V, Page MJ, O'Connor D, Massy-Westropp N, Peters SE. Karjalainen TV, et al. Cochrane Database Syst Rev. 2023 Feb 27;2(2):CD010003. doi: 10.1002/14651858.CD010003.pub2. Cochrane Database Syst Rev. 2023. PMID: 36848651 Free PMC article. Review.
The comparisons included splinting versus no active treatment (or placebo), splinting versus another disease-modifying non-surgical treatment, and comparisons of different splint-wearing regimens. ...We excluded participants if they had previously undergone surgical rel …
The comparisons included splinting versus no active treatment (or placebo), splinting versus another disease-modifying non-surgical t …
Platelets and migraine.
Danese E, Montagnana M, Lippi G. Danese E, et al. Thromb Res. 2014 Jul;134(1):17-22. doi: 10.1016/j.thromres.2014.03.055. Epub 2014 Apr 12. Thromb Res. 2014. PMID: 24767953 Review.
The pathogenesis of migraine, the third most frequent disease worldwide, is complex and multifaceted. Recent evidence suggests that this condition should be considered as a primary neurovascular disorder. ...Increased release of several proinflammatory …
The pathogenesis of migraine, the third most frequent disease worldwide, is complex and multifaceted. Recent evidence suggests that t …
Inherited platelet disorders.
Nurden AT, Freson K, Seligsohn U. Nurden AT, et al. Haemophilia. 2012 Jul;18 Suppl 4:154-60. doi: 10.1111/j.1365-2516.2012.02856.x. Haemophilia. 2012. PMID: 22726100 Review.
MYH9-related diseases) with changes in megakaryocyte maturation within the bone marrow and premature release of platelets. Diseases of platelet production may also affect other cells and in some cases interfere with development and/or functioning of major org …
MYH9-related diseases) with changes in megakaryocyte maturation within the bone marrow and premature release of platelets. Dis …
The Pathophysiology and Management of Acute Traumatic Coagulopathy.
Duan K, Yu W, Li N. Duan K, et al. Clin Appl Thromb Hemost. 2015 Oct;21(7):645-52. doi: 10.1177/1076029613516190. Epub 2013 Dec 19. Clin Appl Thromb Hemost. 2015. PMID: 24363215 Free article. Review.
To date, the possible mechanisms include activation of protein C, shedding of endothelial glycocalyx, catecholamine release, platelet dysfunction, primary, and secondary fibrinolysis, with tissue injury and hypoperfusion as the triggers. ...
To date, the possible mechanisms include activation of protein C, shedding of endothelial glycocalyx, catecholamine release, plate …
Platelet activation markers in evaluation of thrombotic risk factors in various clinical settings.
Kannan M, Ahmad F, Saxena R. Kannan M, et al. Blood Rev. 2019 Sep;37:100583. doi: 10.1016/j.blre.2019.05.007. Epub 2019 May 22. Blood Rev. 2019. PMID: 31133440 Review.
Platelets play a major role in primary hemostasis and thrombus formation. ...The activated platelet expresses certain proteins that are not seen on the resting platelets, thus these proteins serve as markers of platelet activation. ...
Platelets play a major role in primary hemostasis and thrombus formation. ...The activated platelet expresses certain p …
Myelofibrosis with myeloid metaplasia.
Barosi G. Barosi G. Hematol Oncol Clin North Am. 2003 Oct;17(5):1211-26. doi: 10.1016/s0889-8588(03)00080-7. Hematol Oncol Clin North Am. 2003. PMID: 14560783 Review.
MMM is a chronic myeloproliferative disorder characterized by bone marrow fibrosis and neoangiogenesis, constitutive release ofa high number of CD34+ stem cells from the bone marrow, and extramedullary hematopoiesis. ...Animal models suggest that chronic exposure to …
MMM is a chronic myeloproliferative disorder characterized by bone marrow fibrosis and neoangiogenesis, constitutive release o …
Laboratory Techniques Used to Diagnose Constitutional Platelet Dysfunction.
Ibrahim-Kosta M, Alessi MC, Hezard N. Ibrahim-Kosta M, et al. Hamostaseologie. 2020 Nov;40(4):444-459. doi: 10.1055/a-1223-3306. Epub 2020 Sep 15. Hamostaseologie. 2020. PMID: 32932546 Review.
Platelets play a major role in primary hemostasis, where activated platelets form plugs to stop hemorrhaging in response to vessel injuries. ...FC represents an accurate, simple, and reliable test to analyze abnormalities in platelet receptors, and gra …
Platelets play a major role in primary hemostasis, where activated platelets form plugs to stop hemorrhaging in respons …
Advances in diagnosis and treatment of eosinophilia.
Sheikh J, Weller PF. Sheikh J, et al. Curr Opin Hematol. 2009 Jan;16(1):3-8. doi: 10.1097/MOH.0b013e32831c841f. Curr Opin Hematol. 2009. PMID: 19057198 Free PMC article. Review.
PURPOSE OF REVIEW: Hypereosinophilic syndromes (HESs) are disorders characterized by sustained blood or tissue hypereosinophilia or both with subsequent damage to various organs due to eosinophilic infiltration and release of mediators. ...SUMMARY: The contem …
PURPOSE OF REVIEW: Hypereosinophilic syndromes (HESs) are disorders characterized by sustained blood or tissue hypereosinophil …
124 results